Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Munich - Delayed Quote EUR

Sanofi SA (SNW2.MU)

47.20
-1.20
(-2.48%)
As of 8:03:27 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
45.17B
44.29B
41.62B
40.56B
39.17B
Cost of Revenue
13.12B
13.21B
12.63B
11.88B
12.26B
Gross Profit
32.04B
31.08B
28.99B
28.68B
26.92B
Operating Expense
22.01B
21.62B
19.82B
17.75B
17.77B
Operating Income
10.03B
9.46B
9.18B
10.93B
9.15B
Net Non Operating Interest Income Expense
-587.00M
-560.00M
-706.00M
-223.00M
-370.00M
Other Income Expense
-1.72B
-2.20B
-2.22B
-766.00M
-979.00M
Pretax Income
7.72B
6.70B
6.25B
9.94B
7.80B
Tax Provision
1.58B
1.20B
1.02B
1.91B
1.56B
Earnings from Equity Interest Net of Tax
145.00M
60.00M
-136.00M
55.00M
39.00M
Net Income Common Stockholders
6.30B
5.56B
5.40B
8.37B
6.22B
Diluted NI Available to Com Stockholders
6.30B
5.56B
5.40B
8.37B
6.22B
Basic EPS
2.52
2.29
2.15
2.69
2.48
Diluted EPS
2.52
2.29
2.15
2.69
2.48
Basic Average Shares
2.50B
2.50B
2.50B
2.50B
2.50B
Diluted Average Shares
2.50B
2.50B
2.51B
2.50B
2.50B
Total Operating Income as Reported
8.30B
7.25B
6.96B
10.16B
8.13B
Total Expenses
35.14B
34.82B
32.44B
29.64B
30.03B
Net Income from Continuing & Discontinued Operation
6.30B
5.56B
5.40B
8.37B
6.22B
Normalized Income
7.59B
7.30B
6.92B
8.59B
7.01B
Interest Income
352.00M
413.00M
527.00M
239.00M
3.00M
Interest Expense
715.00M
749.00M
710.00M
465.00M
389.00M
Net Interest Income
-587.00M
-560.00M
-706.00M
-223.00M
-370.00M
EBIT
8.44B
7.45B
6.96B
10.40B
8.19B
EBITDA
10.10B
11.03B
11.39B
13.51B
11.54B
Reconciled Cost of Revenue
13.12B
11.37B
10.11B
10.58B
10.48B
Reconciled Depreciation
1.66B
3.59B
4.43B
3.11B
3.35B
Net Income from Continuing Operation Net Minority Interest
6.22B
5.50B
5.06B
7.97B
6.22B
Total Unusual Items Excluding Goodwill
-1.72B
-2.20B
-2.22B
-766.00M
-979.00M
Total Unusual Items
-1.72B
-2.20B
-2.22B
-766.00M
-979.00M
Normalized EBITDA
11.82B
13.24B
13.61B
14.28B
12.52B
Tax Rate for Calcs
0.20
0.18
0.16
0.19
0.20
Tax Effect of Unusual Items
-352.45M
-396.72M
-361.53M
-147.07M
-195.60M
12/31/2021 - 4/17/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RER1.F Recordati Industria Chimica e Farmaceutica S.p.A.
52.05
-1.71%
 
AZNl.XC
 
AZN.ST AstraZeneca PLC
1,343.50
-2.26%
 
NOVN.SW Novartis AG
91.31
-1.73%
 
GRF.MC Grifols, S.A.
8.29
-0.74%
 
ROG.SW Roche Holding AG
266.80
-1.69%
 
AZN.L AstraZeneca PLC
10,476.00
-2.09%
 
BAYN.DE Bayer Aktiengesellschaft
23.75
-1.25%
 
AZN AstraZeneca PLC
70.26
-2.54%
 
JNJ Johnson & Johnson
154.47
-0.34%